We currently have 34 active recruiting sites across Austria, Belgium, Germany, Finland, and Switzerland.
To date, 55 out of the planned 156 patients have been successfully enrolled in the study.
We currently have 34 active recruiting sites across Austria, Belgium, Germany, Finland, and Switzerland.
To date, 55 out of the planned 156 patients have been successfully enrolled in the study.